Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
University of Chicago
This is a multicenter, randomized, placebo-controlled, double blind Phase II clinical trial of pembrolizumab vs. placebo. Patients will be randomized after the completion of curative intent therapy. The primary endpoint is progression-free survival (PFS).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
